82 related articles for article (PubMed ID: 22530010)
1. Survivin as a potential biomarker in the diagnosis of bladder cancer: A systematic review and meta-analysis.
Zhou Z; Zou L; Guan Y; Jiang L; Liu Y; Zhang X; Huang X; Ren H; Li Z; Niu H; Liao H; Zhang X; Pan H; Rong S; Ma H
Urol Oncol; 2024 May; 42(5):133-143. PubMed ID: 38418270
[TBL] [Abstract][Full Text] [Related]
2. Rapid noninvasive detection of bladder cancer using survivin antibody-conjugated gold nanoparticles (GNPs) based on localized surface plasmon resonance (LSPR).
Jazayeri MH; Aghaie T; Nedaeinia R; Manian M; Nickho H
Cancer Immunol Immunother; 2020 Sep; 69(9):1833-1840. PubMed ID: 32350593
[TBL] [Abstract][Full Text] [Related]
3. Identification of survivin as a promising target for the immunotherapy of adult B-cell acute lymphoblastic leukemia.
Boullosa LF; Savaliya P; Bonney S; Orchard L; Wickenden H; Lee C; Smits E; Banham AH; Mills KI; Orchard K; Guinn BA
Oncotarget; 2018 Jan; 9(3):3853-3866. PubMed ID: 29423088
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of a New Survivin ELISA and UBC
Gleichenhagen J; Arndt C; Casjens S; Meinig C; Gerullis H; Raiko I; Brüning T; Ecke T; Johnen G
Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29324722
[TBL] [Abstract][Full Text] [Related]
5. Microplate magnetic chemiluminescence immunoassay for detecting urinary survivin in bladder cancer.
Chang Y; Xu J; Zhang Q
Oncol Lett; 2017 Oct; 14(4):4043-4052. PubMed ID: 28943911
[TBL] [Abstract][Full Text] [Related]
6. Urothelial Bladder Cancer Urinary Biomarkers.
Noon AP; Zlotta AR
EJIFCC; 2014 Apr; 25(1):99-114. PubMed ID: 27683459
[TBL] [Abstract][Full Text] [Related]
7. BcCluster: A Bladder Cancer Database at the Molecular Level.
Bhat A; Mokou M; Zoidakis J; Jankowski V; Vlahou A; Mischak H
Bladder Cancer; 2016 Jan; 2(1):65-76. PubMed ID: 27376128
[TBL] [Abstract][Full Text] [Related]
8. Biomarkers for non-muscle invasive bladder cancer: Current tests and future promise.
Darwiche F; Parekh DJ; Gonzalgo ML
Indian J Urol; 2015; 31(4):273-82. PubMed ID: 26604437
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic and prognostic value of bladder cancer-related transcript markers in urine.
Schmidt J; Propping C; Siow WY; Lohse-Fischer A; Toma M; Baldauf-Twelker A; Hakenberg OW; Wirth MP; Fuessel S
J Cancer Res Clin Oncol; 2016 Feb; 142(2):401-14. PubMed ID: 26328914
[TBL] [Abstract][Full Text] [Related]
10. Survinin expression in patients with breast cancer during chemotherapy.
Marsicano SR; Kuniyoshi RK; Gehrke FS; Alves BC; Azzalis LA; Fonseca FL
Tumour Biol; 2015 May; 36(5):3441-5. PubMed ID: 25537090
[TBL] [Abstract][Full Text] [Related]
11. Chromosomal alterations in exfoliated urothelial cells from bladder cancer cases and healthy men: a prospective screening study.
Bonberg N; Pesch B; Behrens T; Johnen G; Taeger D; Gawrych K; Schwentner C; Wellhäußer H; Kluckert M; Leng G; Nasterlack M; Oberlinner C; Stenzl A; Brüning T
BMC Cancer; 2014 Nov; 14():854. PubMed ID: 25412927
[TBL] [Abstract][Full Text] [Related]
12. eIF3a is over-expressed in urinary bladder cancer and influences its phenotype independent of translation initiation.
Spilka R; Ernst C; Bergler H; Rainer J; Flechsig S; Vogetseder A; Lederer E; Benesch M; Brunner A; Geley S; Eger A; Bachmann F; Doppler W; Obrist P; Haybaeck J
Cell Oncol (Dordr); 2014 Aug; 37(4):253-67. PubMed ID: 25070653
[TBL] [Abstract][Full Text] [Related]
13. Gene microarray analysis of the lncRNA expression profile in human urothelial carcinoma of the bladder.
Luo H; Zhao X; Wan X; Huang S; Wu D
Int J Clin Exp Med; 2014; 7(5):1244-54. PubMed ID: 24995079
[TBL] [Abstract][Full Text] [Related]
14. Screening for bladder cancer with urinary tumor markers in chemical workers with exposure to aromatic amines.
Pesch B; Taeger D; Johnen G; Gawrych K; Bonberg N; Schwentner C; Wellhäusser H; Kluckert M; Leng G; Nasterlack M; Lotan Y; Stenzl A; Brüning T;
Int Arch Occup Environ Health; 2014; 87(7):715-24. PubMed ID: 24129706
[TBL] [Abstract][Full Text] [Related]
15. Cross-contamination of a UROtsa stock with T24 cells--molecular comparison of different cell lines and stocks.
Johnen G; Rozynek P; von der Gathen Y; Bryk O; Zdrenka R; Johannes C; Weber DG; Igwilo-Okuefuna OB; Raiko I; Hippler J; Brüning T; Dopp E
PLoS One; 2013; 8(5):e64139. PubMed ID: 23691160
[TBL] [Abstract][Full Text] [Related]
16. Connexin 26 is down-regulated by KDM5B in the progression of bladder cancer.
Li X; Su Y; Pan J; Zhou Z; Song B; Xiong E; Chen Z
Int J Mol Sci; 2013 Apr; 14(4):7866-79. PubMed ID: 23579952
[TBL] [Abstract][Full Text] [Related]
17. Micropropagation effect on the anti-carcinogenic activitiy of polyphenolics from Mexican oregano (Poliomintha glabrescens Gray) in human colon cancer cells HT-29.
García-Pérez E; Noratto GD; García-Lara S; Gutiérrez-Uribe JA; Mertens-Talcott SU
Plant Foods Hum Nutr; 2013 Jun; 68(2):155-62. PubMed ID: 23435631
[TBL] [Abstract][Full Text] [Related]
18. Performance of survivin mRNA as a biomarker for bladder cancer in the prospective study UroScreen.
Johnen G; Gawrych K; Bontrup H; Pesch B; Taeger D; Banek S; Kluckert M; Wellhäußer H; Eberle F; Nasterlack M; Leng G; Stenzl A; Brüning T;
PLoS One; 2012; 7(4):e35363. PubMed ID: 22530010
[TBL] [Abstract][Full Text] [Related]
19. Prospective evaluation of fluorescence-in situ-hybridization to detect bladder cancer: results from the UroScreen-Study.
Banek S; Schwentner C; Täger D; Pesch B; Nasterlack M; Leng G; Gawrych K; Bonberg N; Johnen G; Kluckert M; Gakis G; Todenhöfer T; Hennenlotter J; Brüning T; Stenzl A;
Urol Oncol; 2013 Nov; 31(8):1656-62. PubMed ID: 22621963
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
